Cell Therapy Market to witness revenue growth of USD 31041.49 Mn through 2023-2027  

Technavio has been monitoring the Cell Therapy Market and it is expected to grow by USD 31041.49 Mn accelerating at a CAGR of  57.06% during the forecast period worldwide. The growth trajectory of the market is traced through a detailed analysis of the prevalent market forces, trends, and drivers along with competitive benchmarking and it has been observed an increase in investments by several research institutes and pharmaceutical companies in cell-based drug development to offer better treatment options to patients is propelling the market advancements.

Leading names such as Astellas Pharma Inc., Athersys Inc., Avita Medical Inc., BioCardia Inc., BioSenic SA, Brainstorm Cell Therapeutics Inc., Bristol Myers Squibb Co., Capricor Therapeutics Inc., Castle Creek Biosciences Inc., CellSeed Inc., Cellular Biomedicine Group Inc., Celyad Oncology SA, Gilead Sciences Inc., Lineage Cell Therapeutics Inc., Lisata Therapeutics Inc., Mesoblast Ltd., Novartis AG, Pharmicell Co. Ltd., Sanpower Group Co. Ltd., and ThermoGenesis Holdings Inc. are some of the major market participants, comes with wide range of offerings and are significantly contributing to the market growth.

Snapshot of the Cell Therapy Market

Navigating through the elements of growth drivers, it has been observed that the cell therapy market growth is the proven effectiveness of CAR T-cell therapy. An increasing preference for VAR-T cell therapies as they tend to have high efficacy when compared to other therapies that exist in the market for the treatment of cancer.

Moreover, the CAR-T cells show an increasing safety profile in children with different types of blood cancers. For instance, Kymriah (tisagenlecleucel), a CAR T-cell therapy developed by Novartis is approved due to its high effectiveness. 

Technavio's research report provides insights into the top market players and their product portfolio along with a pipeline analysis of upcoming developments and growth opportunities. The growth of the players depends on several factors market players must distinguish their product and service offerings through a clear and unique value proposition. Download our best-selling report for more insights on the​​​​​​ Cell Therapy Market worldwide

The report provides insights into the following FAQs:

1. What is the market CAGR?
   The market is accelerating at a CAGR of 57.06%.
    
2. What is the incremental growth of the market?
   The market is expected to grow by USD 31041.49 Mn through 2023-2027.
    
3. What is a key factor driving this market?
   Limitations in traditional organ transplantations fueling demand for cell therapies will drive market growth over the forecast period.
    
4. What are the key regions covered in this market research report?
   North America, Europe, Asia, and Rest of World (ROW) are the key regions featured in this research report.
    
5. Which is the leading geographic region for this market:
   40% growth will originate from North America
    
6. What are the market segments covered in this report?
   The market is segmented by Type (Autologous and Allogenic ), Application (Malignancies, Musculoskeletal, Cardiovascular, and Others ), and Geography (North America, Europe, Asia, and the Rest of World (ROW))